Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: the effect of nasal mupirocin.
Fifteen of 20 hemodialysis patients who carried Staphylococcus aureus in their nares also carried the organism on their hands; 2 of 20 patients who did not carry S aureus in their nares carried S aureus on their hands (P < .001). Eighty-seven percent of patients who carried S aureus in their nares and on their hands carried the same strain at both sites. Intranasal mupirocin eliminated S aureus from both sites.
Boelaert
J R
JR
Unit of Renal and Infectious Diseases, Algemeen Ziekenhuis St Jan, Brugge, Belgium.
Van Landuyt
H W
HW
Gordts
B Z
BZ
De Baere
Y A
YA
Messer
S A
SA
Herwaldt
L A
LA
D000281:Administration, Intranasal; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002353:Carrier State / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D017053:Infection Control; D016712:Mupirocin / Q000627:therapeutic use*; D009297:Nasal Mucosa / Q000382:microbiology*; D006435:Renal Dialysis; D012867:Skin / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus
D000900:Anti-Bacterial Agents; D016712:Mupirocin